David Holland - 31 Oct 2022 Form 4 Insider Report for ALIMERA SCIENCES INC

Role
Chief Marketing Officer & SVP
Signature
/s/ David Holland
Issuer symbol
N/A
Transactions as of
31 Oct 2022
Net transactions value
+$2,218
Form type
4
Filing time
02 Nov 2022, 17:11:51 UTC
Previous filing
03 May 2022
Next filing
28 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALIM Common Stock Award $2,218 +500 +1.2% $4.44 40,880 31 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).